# Major Recall Alert: NRA-Quetiapine XR Recalled Due to Potentially High Levels of N-Nitroso-desalkyl-quetiapine (NDAQ)
Consumers and healthcare professionals, take note: NORA PHARMA INC has issued an urgent recall for specific lots of **NRA-Quetiapine XR**. This critical decision was made after testing revealed that certain lots might **exceed established acceptable intake limits for N-nitroso-desalkyl-quetiapine (NDAQ)**, a compound that can pose health risks if consumed in elevated amounts. Here’s everything you need to know to stay informed and protect yourself.
## Why This Recall is Important
N-nitroso-desalkyl-quetiapine (NDAQ) belongs to the nitrosamine family of compounds, which are recognized as potential carcinogens. Although exposure to small levels of nitrosamines is common in everyday life, **consuming levels above the established intake limit over a prolonged period could increase the risk of certain cancers**.
The recall was announced to prevent potential health complications, including long-term exposure concerns associated with NDAQ. If you, a loved one, or a patient in your care is taking NRA-Quetiapine XR, it’s vital to understand the implications of this recall.
## Details of the Recall
Here’s a breakdown of the critical information for this recall:
- **Category**: Medication Recall in Canada
- **Brand**: NORA PHARMA INC
- **Product**: **NRA-Quetiapine XR** – an extended-release medication prescribed for various mental health conditions, including schizophrenia and bipolar disorder.
- **Reason for Recall**: Certain lots may exceed the established acceptable intake limit for NDAQ.
- **Date Announced**: October 28, 2023
- **Health Risks**: Long-term exposure to high levels of NDAQ could increase the risk of cancer.
To confirm if your medication is affected, please visit the **official recall notice page**: [Government of Canada Recall Alert](https://recalls-rappels.canada.ca/en/alert-recall/nra-quetiapine-xr-some-lots-exceed-intake-limit-n-nitroso-desalkyl-quetiapine-ndaq).
👉 **Image of the Product**:
## What You Should Do
If you are currently using NRA-Quetiapine XR, here are the steps to follow:
- **Stop Use Immediately**: Discontinue use of the affected medication if it has been identified as part of the recalled lots.
- **Contact Your Healthcare Provider**: Speak with your doctor or pharmacist to discuss alternative medications or treatment options.
- **Return the Product**: Return any unused or affected products to the pharmacy where you purchased them, as per the manufacturer’s instructions.
- **Monitor for Symptoms**: While there is no immediate danger with short-term low-level exposure, consult your healthcare provider if you have concerns about long-term health risks.
For additional support, call the **manufacturer's helpline** (details available on the recall source linked above).
## Stay Safe – Get Instant Recall Alerts
Product recalls like this emphasize the importance of staying informed about health and safety updates. Did you know you can get instant recall alerts sent straight to your device?
📱 **Download the MyRecalls App** now to:
- Receive real-time alerts on product and medication recalls.
- Check product safety by simply scanning barcodes.
- Stay updated on critical health and safety issues in your area.
**Don’t wait – Protect yourself and your loved ones today.**
For more details on this recall, visit the official Government of Canada recall page [here](https://recalls-rappels.canada.ca/en/alert-recall/nra-quetiapine-xr-some-lots-exceed-intake-limit-n-nitroso-desalkyl-quetiapine-ndaq). Stay vigilant and informed to ensure your health and safety.